The 44-year-old patient has Hunter syndrome, which doctors hope to treat using zinc finger nucleases.
August 8, 1988|
How will startups get needed capital if the licenses they grant can be voided during court proceedings? WASHINGTON—Steven Mendell says he isn’t worried about the future of his company, Xoma Corp. The seven-year-old Berkeley, California, biotechnology startup firmed up its funding by going public in 1986 and has an agreement with the pharmaceutical giant Pfizer Inc. to help it develop a line of monoclonal antibody-based products to treat septic shock infections. But Mendell, Xoma&